Correction: SVR12 rates higher than 99% after sofosbuvir/velpatasvir combination in HCV infected patients with F0-F1 fibrosis stage: A real world experience
Autoři:
Alessandra Mangia; Valeria Piazzolla; Anna Giannelli; Egidio Visaggi; Nicola Minerva; Vincenzo Palmieri; Immacolata Carraturo; Domenico Potenza; Nicola Napoli; Gianfranco Lauletta; Vincenzo Tagarielli; Rosanna Santoro; Ernesto Piccigallo; Sergio De Gioia; Angelo Chimenti; Giuseppe Cuccorese; Antonio Metrangolo; Michele Mazzola; Ernesto Agostinacchio; Giuseppe Mennea; Carlo Sabbà; Marina Cela; Massimiliano Copetti; Ruggiero Losappio
Vyšlo v časopise:
PLoS ONE 14(9)
Kategorie:
Correction
doi: 10.1371/journal.pone.0223287
Zdroje
1. Mangia A, Piazzolla V, Giannelli A, Visaggi E, Minerva N, Palmieri V, et al. (2019) SVR12 rates higher than 99% after sofosbuvir/velpatasvir combination in HCV infected patients with F0-F1 fibrosis stage: A real world experience. PLoS ONE 14(5): e0215783. https://doi.org/10.1371/journal.pone.0215783 31091254
Článek vyšel v časopise
PLOS One
2019 Číslo 9
Nejčtenější v tomto čísle
Tomuto tématu se dále věnují…
- Anatomical analysis of antebrachial cutaneous nerve distribution pattern and its clinical implications for sensory reconstruction
- Lung clearance index to detect the efficacy of Aztreonam lysine inhalation in patients with cystic fibrosis and near normal spirometry – A single-centre feasibility study
- Correlates of prenatal and postnatal mother-to-infant bonding quality: A systematic review
- CH(II), a cerebroprotein hydrolysate, exhibits potential neuro-protective effect on Alzheimer’s disease
Zvyšte si kvalifikaci online z pohodlí domova
Antiseptika a prevence ve stomatologii
nový kurzVšechny kurzy